Scott Van Wart

594 total citations
14 papers, 426 citations indexed

About

Scott Van Wart is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Scott Van Wart has authored 14 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Scott Van Wart's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (3 papers) and Cancer therapeutics and mechanisms (2 papers). Scott Van Wart is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (3 papers) and Cancer therapeutics and mechanisms (2 papers). Scott Van Wart collaborates with scholars based in United States and Switzerland. Scott Van Wart's co-authors include James Baldassarre, Michael W. Dunne, Sailaja Puttagunta, Chris Rubino, Richard D. Huhn, David L. Cutler, Abhijit Chakraborty, Paul G. Ambrose, Elaine Radwanski and Melton B. Affrime and has published in prestigious journals such as Clinical Infectious Diseases, Clinical Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Scott Van Wart

13 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Van Wart United States	8	206	158	119	115	82	14	426
Mikael Saulay Switzerland	9	142 0.7×	168 1.1×	203 1.7×	111 1.0×	72 0.9×	17	433
Roopali Sharma United States	7	66 0.3×	104 0.7×	69 0.6×	160 1.4×	60 0.7×	21	367
Silvia Arrigucci Italy	8	162 0.8×	80 0.5×	97 0.8×	90 0.8×	32 0.4×	11	362
William Knebel United States	11	233 1.1×	280 1.8×	161 1.4×	60 0.5×	28 0.3×	20	504
Giorgio Mosconi Italy	7	116 0.6×	235 1.5×	76 0.6×	68 0.6×	68 0.8×	9	362
Michael Dudley United States	15	163 0.8×	92 0.6×	76 0.6×	223 1.9×	19 0.2×	26	431
Ye Zhang China	16	60 0.3×	74 0.5×	170 1.4×	102 0.9×	49 0.6×	57	609
A.P. Gillett United Kingdom	10	286 1.4×	74 0.5×	109 0.9×	156 1.4×	41 0.5×	22	463
Mika Ishihara Japan	13	197 1.0×	243 1.5×	81 0.7×	21 0.2×	44 0.5×	24	447
Huang-Shen Lin Taiwan	12	54 0.3×	51 0.3×	119 1.0×	102 0.9×	41 0.5×	21	299

Countries citing papers authored by Scott Van Wart

Since Specialization

Citations

This map shows the geographic impact of Scott Van Wart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Van Wart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Van Wart more than expected).

Fields of papers citing papers by Scott Van Wart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Van Wart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Van Wart. The network helps show where Scott Van Wart may publish in the future.

Co-authorship network of co-authors of Scott Van Wart

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Van Wart. A scholar is included among the top collaborators of Scott Van Wart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Van Wart. Scott Van Wart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Li, Cheryl, Scott Van Wart, Lili Yang, et al.. (2025). Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling of Serum M‐Protein Response for Modakafusp Alfa in a Phase 1/2 Study of Patients With Relapsed or Refractory Multiple Myeloma. Clinical and Translational Science. 18(7). e70296–e70296. 1 indexed citations

Shord, Stacy S., Cong Chen, Jin Y. Jin, et al.. (2025). FDA–AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Optimized Dosages for Registrational Trials. Clinical Cancer Research. 31(23). 4891–4898.

Wart, Scott Van, et al.. (2021). Population Pharmacokinetic Model of N-acetylmannosamine (ManNAc) and N-acetylneuraminic acid (Neu5Ac) in Subjects with GNE Myopathy. Drugs in R&D. 21(2). 189–202. 7 indexed citations

Lodise, Thomas P., Scott Van Wart, Zoë Sund, et al.. (2020). Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN). Antimicrobial Agents and Chemotherapy. 65(3). 35 indexed citations

Gall, Jonathan M., et al.. (2019). A Phase 1 Study of Intravenous Plazomicin in Healthy Adults to Assess Potential Effects on the QT/QTc Interval, Safety, and Pharmacokinetics. Clinical Pharmacology in Drug Development. 8(8). 1032–1041. 11 indexed citations

Gibbons, Jacqueline A., et al.. (2018). A Phase 1 Study To Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function. Antimicrobial Agents and Chemotherapy. 62(12). 11 indexed citations

Dunne, Michael W., et al.. (2015). Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue. Antimicrobial Agents and Chemotherapy. 59(4). 1849–1855. 179 indexed citations

Rhodes, Nathaniel J., Joseph L. Kuti, David P. Nicolau, et al.. (2015). Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival. Antimicrobial Agents and Chemotherapy. 60(3). 1401–1410. 50 indexed citations

Marathe, Anshu, Scott Van Wart, & Donald E. Mager. (2010). Impact of dose selection on parameter estimation using a rapid binding approximation model of target-mediated drug disposition. Journal of Pharmacokinetics and Pharmacodynamics. 38(2). 223–235. 2 indexed citations

10.

Ambrose, Paul G., Jack B. Anon, Joel Owen, et al.. (2004). Use of Pharmacodynamic End Points in the Evaluation of Gatifloxacin for the Treatment of Acute Maxillary Sinusitis. Clinical Infectious Diseases. 38(11). 1513–1520. 33 indexed citations

11.

Wart, Scott Van, Elizabeth Ludwig, Akintunde Bello, et al.. (2004). Population Pharmacokinetics and Pharmacodynamics of Garenoxacin in Patients with Community-Acquired Respiratory Tract Infections. Antimicrobial Agents and Chemotherapy. 48(12). 4766–4777. 39 indexed citations

12.

Wart, Scott Van, et al.. (2000). POPULATION PHARMACOKINETICS OF TIGECYCLINE IN PHASE 1 SUBJECTS. 2 indexed citations

13.

Meno‐Tetang, Guy, Yuen Yi Hon, Scott Van Wart, & W J Jusko. (1999). Pharmacokinetic and Pharmacodynamic Interactions between Dehydroepiandrosterone and Prednisolone in the Rat. Drug metabolism and drug interactions. 15(1). 51–70. 3 indexed citations

14.

Radwanski, Elaine, Abhijit Chakraborty, Scott Van Wart, et al.. (1998). Pharmacokinetics and Leukocyte Responses of Recombinant Human Interleukin-10. Pharmaceutical Research. 15(12). 1895–1901. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact